Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Search content at Albert Einstein College of Medicine
Home
Faculty
Departments
Grants
Publications
Prizes
Modern management of chronic myelogenous leukemia (CML)
Eric J. Feldman
, Zalmen A. Arlin
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Modern management of chronic myelogenous leukemia (CML)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Myeloid Leukemia
100%
Modern Management
100%
Remission
50%
Aggressive Therapy
33%
Blastic Phase
33%
Hematologic
16%
Chemoradiotherapy
16%
Chemotherapy
16%
Therapeutic Potential
16%
Median Survival
16%
Chronic Phase
16%
Acute Myeloid Leukemia
16%
Philadelphia Chromosome
16%
Acute Leukemia
16%
Intensive Care Medicine
16%
Marrow Transplantation
16%
State Patient
16%
Terminal Phase
16%
Five Decades
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myeloid Leukemia
100%
Remission
50%
Disease
33%
Chemoradiation Therapy
16%
Chemotherapy
16%
Physical Disease by Body Function
16%
Acute Myeloid Leukemia
16%
Immunotherapy
16%
Acute Leukemia
16%
Philadelphia 1 Chromosome
16%
Medicine and Dentistry
Chronic Myelogenous Leukemia
100%
Disease
33%
Chemoradiotherapy
16%
Physical Disease by Body Function
16%
Acute Myeloid Leukemia
16%
Intensive Care
16%
Acute Leukemia
16%
Immunotherapy
16%
Philadelphia 1 Chromosome
16%
Cell pH
16%
Nursing and Health Professions
Cell pH
16%
Philadelphia 1 Chromosome
16%